This product is an antibiotic with broad-spectrum antibacterial effect and is suitable for skin inflammation caused by Gram-positive or Gram-positive bacteria.

It is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide, both of which are important coenzymes for tissue respiration. It can also activate vitamin B6, convert tryptophan into niacin, and may be related to maintaining the integrity of red blood cells.

Vitamin B2 is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide, both of which are important coenzymes for tissue respiration. It can also activate vitamin B6 and convert amino acids into niacin, and may be related to maintaining the integrity of red blood cells.

As a part of riboflavin, it participates in tissue respiration and various metabolic processes.

Vitamin B2 is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide, both of which are important coenzymes for tissue respiration. It can also activate vitamin B6 and convert amino acids into niacin, and may be related to maintaining the integrity of red blood cells.

Vitamin B2 is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide, both of which are important coenzymes for tissue respiration. It can also activate vitamin B6 and convert amino acids into niacin, and may be related to maintaining the integrity of red blood cells.

Vitamin B2 is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide, both of which are important coenzymes for tissue respiration. It can also activate vitamin B6 and convert amino acids into niacin, and may be related to maintaining the integrity of red blood cells.

Extract from the above information

This product is a pyrimidine antimetabolite drug, which mainly inhibits dihydrofolate reductase, interferes with folic acid metabolism, and selectively inhibits the synthesis of DNA, RNA and protein. It is a cycle-specific drug and has no cross-resistance with alkylating agents.

This product has a broad-spectrum antimicrobial effect in vitro, including aerobic Gram-negative and Gram-positive bacteria, anaerobes, Rickettsia, spirochetes and Chlamydia. It has bactericidal effects on the following bacteria: Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis. It only has antibacterial effects on the following bacteria: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Group B hemolytic Streptococcus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella typhi, Salmonella paratyphi, Shigella, Bacteroides fragilis and other anaerobic bacteria. The following bacteria are usually resistant to chloramphenicol: Pseudomonas aeruginosa, Acinetobacter, Enterobacter, Serratia marcescens, indole-positive Proteus, methicillin-resistant Staphylococcus and Enterococcus. This product is an antibacterial agent. Chloramphenicol is fat-soluble and its mechanism of action is to diffuse into bacterial cells and reversibly bind to the 50S subunit of bacterial ribosomes, thereby hindering the growth of peptide chains (possibly due to the inhibition of transpeptidase), thereby inhibiting the formation of peptide chains and preventing protein synthesis.